Evidence map›Paper›PMID 37810191›Full record

Article3 Biotech2023

Development and evaluation of an anti-candida cream based on silver nanoparticles.

Antônio Auberson Martins Maciel, Francisco Afrânio Cunha, Tiago Melo Freire, Fernando Lima de Menezes, Lillian Maria Uchoa Dutra Fechine, Janaina Sobreira Rocha, Rita de Cássia Carvalho Barbosa, Roxeane Teles Martins, Maria da Conceição Dos Santos Oliveira Cunha, Ralph Santos-Oliveira and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Antônio Auberson Martins MacielAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Francisco Afrânio CunhaAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Tiago Melo FreireAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Fernando Lima de MenezesAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Lillian Maria Uchoa Dutra FechineAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Janaina Sobreira RochaAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.
Rita de Cássia Carvalho BarbosaDepartament of Clinical and Toxicological Analysis, Federal University of Ceará (UFC), Capitão Francisco Pedro Street, 1210, Rodolfo Teófilo, Fortaleza, CE 60270-430 Brazil.
Roxeane Teles MartinsDepartament of Clinical and Toxicological Analysis, Federal University of Ceará (UFC), Capitão Francisco Pedro Street, 1210, Rodolfo Teófilo, Fortaleza, CE 60270-430 Brazil.
Maria da Conceição Dos Santos Oliveira CunhaState University of Ceará. Graduate Program in Clinical Care in Nursing and Health, Fortaleza, CE Brazil.
Ralph Santos-OliveiraLaboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro, RJ 21941906 Brazil.
Maria Veraci Oliveira QueirozState University of Ceará. Graduate Program in Clinical Care in Nursing and Health, Fortaleza, CE Brazil.
Pierre Basílio Almeida FechineAdvanced Materials Chemistry Group (GQMat), Department of Analytical Chemistry and Physical Chemistry, Federal University of Ceará (UFC), Pici Campus, 12100, Fortaleza, CE 60451-970 Brazil.ORCID 0000-0002-7822-2354
Universidade Federal do Ceará · BRUniversidade Estadual do Ceará · BRUniversidade Estadual da Zona Oeste · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ineffectiveness of azole drugs in treating Vulvovaginal Candidiasis (VVC) and Recurrent Vulvovaginal Candidiasis (RVVC) due to antifungal resistance of non-albicans Candida has led to the investigation of inorganic nanoparticles with biological activity. Silver nanoparticles (AgNPs) are important in nanomedicine and have been used in various products and technologies. This study aimed to develop a vaginal cream and assess its in vitro antimicrobial activity against

Indexed as

Antifungal activityCandidaMiconazoleSilver nanoparticles

Identifiers

PMID37810191
PMCPMC10550885
OpenAlexW4387338446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.